Drug Discovery Research Laboratories, Research Division, Kyowa Hakko Kirin, Nagaizumi-cho, Sunto-gun, Shizuoka 411-8731, Japan.
Anal Biochem. 2010 May 15;400(2):163-72. doi: 10.1016/j.ab.2010.01.036. Epub 2010 Feb 1.
We have established a cAMP response element (CRE)-mediated reporter assay system for G-protein-coupled receptors (GPCRs) using an oriP-based estrogen-inducible expression vector and the B-cell line (GBC53 or GBCC71) that expresses EBNA-1 and is adapted to serum-free culture. GBC53 harbors a GAL4-ER expression unit and a CRE-luciferase gene in the genome, and GBCC71 also harbors expression units for two chimeric Galphas proteins (Gs/q and Gs/i). Introduction of a GPCR expression plasmid into GBC53 or GBCC71 creates polyclonal stable transformants in 2 weeks, and these are easily expanded and used for assays after induction of the GPCR expression. Using GBC53, we detected ligand-dependent signals of Gs-coupled GPCRs such as glucagon-like peptide 1 receptor (GLP1R) and beta2 adrenergic receptor (beta2AR) with high sensitivity. Interestingly, we also detected constitutive activity of beta2AR. Using GBCC71, we detected ligand-dependent signals of Gq- or Gi-coupled GPCRs such as H1 histamine receptor and CXCR1 chemokine receptor in addition to Gs-coupled GPCRs. An agonist, antagonist, or inverse agonist was successfully evaluated in this system. We succeeded in constructing a 384-well high-throughput screening (HTS) system for GLP1R. This system enabled us to easily and rapidly make a large number of efficient GPCR assay systems suitable for HTS as well as ligand hunting of orphan GPCRs.
我们建立了一个基于 cAMP 反应元件 (CRE) 的 G 蛋白偶联受体 (GPCR) 报告基因检测系统,该系统使用基于 oriP 的雌激素诱导表达载体和表达 EBNA-1 并适应无血清培养的 B 细胞系 (GBC53 或 GBCC71)。GBC53 基因组中含有一个 GAL4-ER 表达单元和一个 CRE-荧光素酶基因,GBCC71 还含有两个嵌合 Galphas 蛋白 (Gs/q 和 Gs/i) 的表达单元。将 GPCR 表达质粒导入 GBC53 或 GBCC71 中,可在 2 周内创建多克隆稳定转化体,这些转化体易于扩增,并可在诱导 GPCR 表达后用于检测。使用 GBC53,我们以高灵敏度检测到了 Gs 偶联 GPCR 如胰高血糖素样肽 1 受体 (GLP1R) 和 β2 肾上腺素能受体 (β2AR) 的配体依赖性信号。有趣的是,我们还检测到了 β2AR 的组成性活性。使用 GBCC71,我们除了检测到 Gs 偶联 GPCR 如 H1 组胺受体和 CXCR1 趋化因子受体的配体依赖性信号外,还检测到了 Gq 或 Gi 偶联 GPCR 的配体依赖性信号。在该系统中,激动剂、拮抗剂或反向激动剂都能成功进行评价。我们成功构建了 GLP1R 的 384 孔高通量筛选 (HTS) 系统。该系统使我们能够轻松快速地构建大量适合 HTS 以及孤儿 GPCR 配体搜索的高效 GPCR 检测系统。